Related Experiment Videos
Ibuprofen in experimental group B streptococcal shock
K J Peevy1, R D Ronnlund, S A Chartrand
1Department of Pediatrics, University of South Alabama, Mobile 36617.
Circulatory Shock
|January 1, 1988
Summary
Ibuprofen pretreatment improved short-term survival in a rabbit model of group B streptococcal (GBS) shock. However, ibuprofen modified but did not prevent GBS-induced shock or its hematologic complications.
Area of Science:
- Pharmacology
- Microbiology
- Animal Models
Background:
- Group B Streptococcus (GBS) can cause severe shock with significant hemodynamic and hematologic alterations.
- Understanding the therapeutic potential of non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen in managing GBS-induced shock is crucial.
Purpose of the Study:
- To investigate the effects of high and low doses of ibuprofen on the hemodynamic and hematologic manifestations of GBS shock in a rabbit model.
- To determine if ibuprofen can prevent or favorably modify the pathological consequences of GBS infection.
Main Methods:
- A rabbit model was utilized to induce GBS shock.
- Animals were pretreated with either high-dose (100 mg/kg) or low-dose (10 mg/kg) ibuprofen.
- Hemodynamic parameters, hematologic markers, and specific biochemical indicators (6KPGF1a, TxB2) were monitored.
Main Results:
- Ibuprofen pretreatment significantly increased short-term survival rates.
- While ibuprofen did not prevent GBS-induced shock, it favorably modified shock severity in a dose-dependent manner.
- Increases in 6KPGF1a and TxB2 were modified by high-dose ibuprofen, but neutropenia, thrombocytopenia, and acidosis were not prevented and potentially worsened.
Conclusions:
- Ibuprofen demonstrates a dose-dependent ability to favorably modify, but not prevent, the hemodynamic and hematologic derangements associated with GBS shock.
- Further research is needed to elucidate the complex interactions between ibuprofen and GBS pathogenesis.